Zobrazeno 1 - 10
of 16
pro vyhledávání: '"M. J. Carreras"'
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
J. Cortés, J. Baselga, Patricia Gomez, Meritxell Bellet, L. De Mattos-Arruda, Eva Muñoz-Couselo, Maria Vidal, César Serrano, G. Sánchez-Ollé, Cristina Saura, José Francisco Pérez, M. J. Carreras, J. Tabernero, S. Di Cosimo
Publikováno v:
Annals of Oncology. 30:1178
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::fef8e246976cae3ff13b6274c72a51e4
https://doi.org/10.1093/annonc/mdy534
https://doi.org/10.1093/annonc/mdy534
Autor:
E. Sicart, M. J. Carreras, Jaume Capdevila, Caroline O. Michie, Martin Cullell-Young, Sally Clive, C. Coronado, A. Soto Matos-Pita, Carmen Kahatt, A. Piera, C. Fernandez Teruel, Esther Casado, Josep Tabernero, Mariano Siguero
Publikováno v:
Cancer Chemotherapy and Pharmacology. 71:1247-1254
PM00104 (Zalypsis) is a synthetic tetrahydroisoquinoline alkaloid with potent antiproliferative activity against tumor cell lines. This phase I study evaluated the safety, dose-limiting toxicities (DLTs), recommended dose for phase II trials (RD), ph
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::9e602ad22dff99fcc1e88b63b9453924
https://doi.org/10.1007/s00280-013-2119-8
https://doi.org/10.1007/s00280-013-2119-8
Autor:
Ana Vivancos, M. Abu-Suboh, Joaquín Arribas, C. Bernadó Morales, J. Balsells, F. Bilal, Irit Sagi, V. Mohan, Katrina S. Pedersen, María Teresa Salcedo, Daniel Massó-Vallés, Josep Tabernero, Xavier Serres, E. Allende, Teresa Macarulla, Laura Soucek, M. J. Carreras
Publikováno v:
Oncogene. 36(40)
Our increasing knowledge of the mechanisms behind the progression of pancreatic cancer (PC) has not yet translated into effective treatments. Many promising drugs have failed in the clinic, highlighting the need for better preclinical models to asses
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::697b0028009e6bc327f12e637babc70f
https://pubmed.ncbi.nlm.nih.gov/28581516
https://pubmed.ncbi.nlm.nih.gov/28581516
Autor:
Maria Vidal, Eva Muñoz-Couselo, Meritxell Bellet, G. Sánchez-Ollé, L. De Mattos-Arruda, Javier Cortes, S. Di Cosimo, Cristina Saura, José Baselga, M. J. Carreras, César Serrano, Jose Manuel Trigo Perez, Patricia Gomez, Josep Tabernero
Publikováno v:
Annals of Oncology. 23:897-902
Background Elderly breast cancer patients are usually excluded from clinical trials. Nevertheless, with the increasing use of trastuzumab, there is a need to address trastuzumab-related cardiotoxicity in this population. Patients and methods Records
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::bff19a7dcdeec0e276cda7961211cef5
https://doi.org/10.1093/annonc/mdr348
https://doi.org/10.1093/annonc/mdr348
Autor:
Jordi Andreu, Shefali Agarwal, Maria Herranz, May Han, Marc Credi, Wei Yin, Maria Elena Elez, James Gifford, Philip Komarnitsky, Isabel Rico, Jose Mateos, Josep Tabernero, Ludmila Prudkin, José Baselga, M. J. Carreras
Publikováno v:
Clinical cancer research : an official journal of the American Association for Cancer Research. 20(10)
Purpose: This study evaluated the safety, tolerability, pharmacodynamics, pharmacokinetics, and antitumor activity of ficlatuzumab, a humanized hepatocyte growth factor (HGF) inhibitory monoclonal antibody, as monotherapy in patients with advanced so
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4a5d18deb4d40c69babada3e36485c24
https://pubmed.ncbi.nlm.nih.gov/24634378
https://pubmed.ncbi.nlm.nih.gov/24634378
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Maja J.A. de Jonge, James P. O'Brien, Erik A.C. Wiemer, Yoshiharu Mizui, Ferry A.L.M. Eskens, José Baselga, M. J. Carreras, Adelaida Piera, Francisco Javier Ramos, Josep Tabernero, Herman Burger
Publikováno v:
Clinical Cancer Research, 19(22), 6296-6304. American Association for Cancer Research Inc.
Purpose: To assess the safety, tolerability, pharmacokinetics, pharmacodynamics, and clinical activity of E7107 administered as 5-minute bolus infusions on days 1, 8, and 15 in a 28-day schedule. Experimental Design: Patients with solid tumors refrac
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::09462664157ef5dc8aa10d37b8b26380
https://pure.eur.nl/en/publications/c5bba513-919f-4187-8e4e-9f4209779c30
https://pure.eur.nl/en/publications/c5bba513-919f-4187-8e4e-9f4209779c30
Autor:
M. J. Carreras, Cristina Saura, José Francisco Pérez, J. Cortes, Patricia Gomez, Meritxell Bellet, J. Baselga, S. Di Cosimo, César Serrano, Michelangelo Russillo
Publikováno v:
European Journal of Cancer Supplements. 7:216
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::a8fdcb4b5b0a89a4bd49096a3978fbec
https://doi.org/10.1016/s1359-6349(09)70739-6
https://doi.org/10.1016/s1359-6349(09)70739-6